A Phase I Study Using Bortezomib (Velcade, Formerly Known as PS-341) With Weekly Idarubicin For the Treatment of Elderly (>60 Years) and Relapsed Patients with Acute Myelogenous Leukemia

  • Howard, Dianna (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/30/04 → 7/31/10